BCL-XL is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy

International Journal of Cancer

Volumn 99, Issue 1, 2002, Pages 29-34

  Heere Ress, Elisabeth ^a   Thallinger, Christiane ^a   Lucas, Trevor ^a   Schlagbauer Wadl, Hermine ^a   Wacheck, Volker ^a   Monia, Brett P ^b   Wolff, Klaus ^a   Pehamberger, Hubert ^a,c   Jansen, Burkhard ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b ISIS PHARMACEUTICALS   (United States)

^c LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Antisense oligonucleotide; Apoptosis; Bcl xL; Chemoresistance; Melanoma

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CISPLATIN; ISIS 16009; ISIS 16967; PHOSPHOROTHIOIC ACID DERIVATIVE; PROTEIN BCL XL; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL LINE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SENSITIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; R FACTOR;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-X PROTEIN; BLOTTING, WESTERN; CELL SURVIVAL; CISPLATIN; DRUG RESISTANCE; FLOW CYTOMETRY; HUMANS; MELANOMA; OLIGONUCLEOTIDES, ANTISENSE; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; SKIN NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0036568524     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10248     Document Type: Article

References (45)

1. Cancer statistics, 1994
2. The chemoresistance of human malignant melanoma: An update
3. Apoptosis in the pathogenesis and treatment of disease
4. Anticancer drug resistance and inhibition of apoptosis
5. The proto-oncogene Bcl-2 and its role in regulating apoptosis
6. Dysregulation of apoptosis in cancer
7. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
8. L can confer a multidrug resistance phenotype
9. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas
10. s through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides
11. L
12. L can differentially block chemotherapy-induced cell death
13. L in advanced malignant melanoma
14. From bench to clinic with apoptosis-based therapeutic agents
15. Expression of Bcl-2 family members in human melanocytes, in melanoma metastases and in melanoma cell lines
16. Antisense approaches for the treatment of cancer
17. Chemosensitisation of malignant melanoma by BCL2 antisense therapy
18. BCL-2 antisense therapy in patients with non-Hodgkin lymphoma
19. Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma
20. The role of antiapoptotic Bcl-2 family members in endothelial apoptosis elucidated with antisense oligonucleotides
21. L anti-sense treatment
22. L and antisense Bcl-2 oligonucleotides plus Taxol after castration in the Shionogi tumor model
23. Eradication of human non-Hodgkin's lymphoma in SCID mice by BCL-2 antisense oligonucleotides combined with low-dose cyclophosphamide
24. L is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis
25. L is expressed in ovarian carcinoma and modulates chemotherapy-induced apoptosis
26. Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases
27. L antisense treatment induces apoptosis in breast carcinoma cells
28. L in prostate cancer cells: Effects of overexpression and down-regulation on chemosensitivity
29. L protein levels on chemoresistance of hepatoblastoma HepG2 cell line
30. MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily
31. L expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuli
32. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
33. L protects pancreatic adenocarcinoma cells against
34. DNA excision repair and DNA damage-induced apoptosis are linked to poly(ADP-ribosyl)ation but have different requirements for p53
35. L
36. BCL-2 family: Regulators of cell death
37. L expression efficiently induces apoptosis in tumor cells
38. Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2
39. Expression of apoptosis regulators in cutaneous malignant melanoma
40. Systemic chemotherapy for metastatic melanoma
41. Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-alpha
42. Dacarbazine-based chemotherapy for metastatic melanoma: Thirty-year experience overview
43. bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice
44. L-bispecific antisense oligonucleotide against tumors of diverse histologic origins
45. Bcl-x(L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation